Skip to main content
Log in

K-FGF mediated transformation and induction of metastatic potential involves altered ornithine decarboxylase and S-adenosylmethionine decarboxylase expression – role in cellular invasion

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (SAMDC) expression was investigated in NIH-3T3 fibroblasts that secrete K-FGF. Correlations between altered ODC and SAMDC expression and malignant potential were determined. Increased ODC and SAMDC expression was associated with increased expression of both ODC and SAMDC mRNA and enzyme activity levels. Transcriptional and post-transcriptional regulatory mechanisms were found to account for the increased expression of both ODC and SAMDC. Amplification of the ODC gene also played a role. Correlations between the expression of ODC and the invasion ability of the K-FGF overexpressing cells were also found. Additionally, putrescine, which is a cellular polyamine, was found to play a role in determining the nature of the invasive capacity of the K-FGF overexpressing cells. The results of this study which established correlations between alterations in the expression of ODC and SAMDC, the key rate limiting and regulatory activities in the synthesis of cellular polyamines, and malignant potential as a consequence of K-FGF overexpression supports a model which suggests that growth factor modulation of ODC and SAMDC expression is part of the altered growth regulatory program associated with cellular transformation and malignant progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wright JA, Egan SE, Greenberg AH: Genetic regulation of metastatic progression. Anticancer Res 10: 1247–1255, 1990

    Google Scholar 

  2. Wright JA, Turley EA, Greenberg AH: Transforming growth factor beta and basic fibroblast growth factor as promoters of tumor progression to malignancy. Crit Rev Oncogene 4: 473–492, 1993

    Google Scholar 

  3. Egan SE, Jarolim L, Rogelj S, Spearman M, Wright JA, Greenberg AH: Growth factor modulation of metastatic lung colonization. Anticancer Res 10: 1341–1346, 1990

    Google Scholar 

  4. Tiesman J, Rizzino A: Expression and developmental regulation of the K-FGF oncogene in human and murine embryonal carcinoma cells. In Vitro Cell Dev Biol 25: 1193–1201, 1989

    Google Scholar 

  5. Yoshida MC, Wada M, Satoh H, Yoshida T, Sakamoto H, Miyagawa K, Yokota J, Koda T, Kakinuma M, Sigimura T, Terada M: Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer. Proc Natl Acad Sci USA 85: 4861–4864, 1988

    Google Scholar 

  6. Theillet C, LeRoy X, DeLapeyriere O, Grosgeorges J, Adnane J, Raynaud SD, Simony-Lafonatine J, Goldfarb M, Escot C, Birnbaum D, Gaudray P: Amplification of FGF-related genes in human tumors: Possible involvement of HST in breast carcinomas. Oncogene 4: 915–922, 1989

    Google Scholar 

  7. Damen JE, Greenberg AH, Wright JA: Transformation and amplification of the K-fgf proto-oncogene in NIH-3T3 cells and the induction of metastatic potential. Biochim Biophys Acta 1097: 103–110, 1991

    Google Scholar 

  8. Taylor WR, Greenberg AH, Turley EA, Wright JA: Cell motility, invasion and malignancy induced by overexpression of K-FGF or bFGF. Exp Cell Res 204: 295–301, 1993

    Google Scholar 

  9. Delli-Bovi P, Curatola AM, Newman KM, Sato Y, Moscatelli D, Hewick RM, Rifkin DB, Basilico C: Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential. Mol Cell Biol 8: 2933–2941, 1988

    Google Scholar 

  10. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48: 759–774, 1988

    Google Scholar 

  11. Hurta RAR, Greenberg AH, Wright JA: Transforming growth factor beta1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines. J Cell Physiol 156: 272–279, 1993

    Google Scholar 

  12. Hurta RAR, Wright JA: Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H-ras transformed cell lines. J Cell Physiol 161: 383–391, 1994

    Google Scholar 

  13. Hurta RAR, Huang A, Wright JA: Basic fibroblast growth factor selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed cells. J Cell Biochem 60: 572–583, 1996

    Google Scholar 

  14. Kontula KK, Torkkeli TK, Bardin W, Janne OA: Androgen induction of ornithine decarboxylase mRNA in mouse kidney as studied by complementary DNA. Proc Natl Acad Sci USA 81: 731–735, 1984

    Google Scholar 

  15. Kahana C, Nathans D: Translational regulation of mammalian ornithine decarboxylase by polyamines. J Biol Chem 260: 15390–15393, 1985

    Google Scholar 

  16. Persson I, Oredsson SM, Aanehus S, Heby O: Ornithine decarboxylase inhibitors increase the cellular content of the enzyme: Implications for translational regulation. Biochem Biophys Res Commun 131: 239–245, 1985

    Google Scholar 

  17. Hovis JG, Stumpo DJ, Halsey DL, Blackshear PJ: Effects of mitogens on ornithine decarboxylase activity and messenger RNA levels in normal and in protein kinase C-deficient NIH-3T3 fibroblasts. J Biol Chem 261: 10380–10386, 1986

    Google Scholar 

  18. Sertich GJ, Pegg AE: Polyamine administration reduces ornithine decarboxylase activity without affecting its mRNA content. Biochem Biophys Res Commun 143: 424–430, 1987

    Google Scholar 

  19. Heby O, Persson L: Molecular genetics of polyamine biosynthesis in eukaryotic cells. Trends Biochem Sci 15: 153–158, 1990

    Google Scholar 

  20. Pegg AE, McCann PP: S-adenosylmethionine decarboxylase as an enzyme target for therapy. In: W.C. Bowman, A.M. Breckenridge, A.C. Sartorelli (eds). Pharmacological Therapeutics, vol. 56. Pergamon Press, New York, 1992, pp 359–377.

    Google Scholar 

  21. Wallon UM, Shassetz LR, Cress AE, Bowden GT, Gerner EW: Polyamine-dependent expression of the matrix metalloproteinase matrilysin in a human colon cancer-derived cell line. Mol Carcinogen 11: 138–144, 1994

    Google Scholar 

  22. Ray R, Zimmerman BJ, McCormack SA, Patel TB, Johnson LR: Polyamine inhibitors arrest cell cycle and induces inhibitors p21Waf1Cip1, p27Kip1, and p53 in IEC-6 cells. Am J Physiol C684–C691, 1999

  23. Kaminska B, Kaczmarek L, Grzelakowska-Szabert B: Inhibitors of polyamine biosynthesis affect the expression of gene encoding cytoskeletal proteins. FEBS Lett 304: 198–200, 1992

    Google Scholar 

  24. Tabib A, Bachrach U: Polyamines induce malignant transformation in cultured NIH3T3 fibroblasts. Int J Biochem Cell Biol 30: 135–146, 1998

    Google Scholar 

  25. Tabib A, Bachrach U: Role of polyamines in mediating malignant transformation and oncogene expression. Int J Biochem Cell Biol 31: 12899–1295, 1999

    Google Scholar 

  26. Manni A, Badger B, Grove R, Kunselman S, Demers L: Isolation and characterization of human breast cancer cells overexpressing S-adenosylmethionine decarboxylase. Cancer Lett 95: 23–28, 1995

    Google Scholar 

  27. Kubota S, Yamada T, Kamei S, Seyama Y: Ornithine decarboxylase is directly involved in mouse mammary carcinoma cell invasion in vitro. Biochem Biophys Res Commun 208: 1106–1115, 1995

    Google Scholar 

  28. Kubota S, Kiyosawa H, Nomura Y, Yamada T, Seyama Y: Ornithine decarboxylase overexpression in mouse 10T1/2 fibroblasts: Cellular transformation and invasion. J Natl Can Inst 89: 567–571, 1997

    Google Scholar 

  29. Ashida Y, Kido J, Kinoshita F, Nishino M, Shinkai K, Akedo H, Inoue H: Putrescine-dependent invasive capacity of rat ascites hepatoma cells. Cancer Res 52: 5313–5316, 1992

    Google Scholar 

  30. Hurta RAR, Wright JA: Amplification of the genes for both components of ribonucleotide reductase in hydroxyurea resistant mammalian cells, Biochem Biophys Res Commun 167: 258–264, 1990

    Google Scholar 

  31. Wang J-Y, Viar MJ, McCormack SA, Johnson LR: Effect of putrescine on S-adenosylmethionine decarboxylase in a small intestinal crypt cell line. Am J Physiol G494–G501, 1992

  32. Patel AR, Li J, Bass BL, Wang J-Y: Expression of the transforming growth factor beta gene during growth inhibition following polyamine depletion. Am J Physiol C590–C597, 1998

  33. deBustros A, Baylin SB, Berger CL, Roos BA, Leong SS, Nelkin BD: Phorbol esters increase calcitonin gene transcription and decrease cmyc RNA levels in cultured human medullary thyroid carcinoma. J Biol Chem 260: 98–104, 1985

    Google Scholar 

  34. Huang A, Jin H, Wright JA: Aberrant expression of basic fibroblast growth factor in NIH-3T3 cells alters drug resistance and gene amplification potential. Exp Cell Res 213: 335–339, 1994

    Google Scholar 

  35. Auvinen M, Paasinen A, Andersson LC, Holtta E: Ornithine decarboxylase activity is critical for cell transformation. Science 360: 355–357, 1992

    Google Scholar 

  36. Auvinen M: Cell transformation, invasion and angiogenesis: A regulatory role for ornithine decarboxylase and polyamines? J Natl Cancer Inst 89: 533–537, 1997

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hardin, M.S., Mader, R. & Hurta, R.A. K-FGF mediated transformation and induction of metastatic potential involves altered ornithine decarboxylase and S-adenosylmethionine decarboxylase expression – role in cellular invasion. Mol Cell Biochem 233, 49–56 (2002). https://doi.org/10.1023/A:1015554006581

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015554006581

Navigation